Strategic Growth Opportunities in the Gene Therapy for Age-Related...

adicionou um novo artigo Health

2026-08-05 14:00:13 - Traduzir -

Strategic Growth Opportunities in the Gene Therapy for Age-Related Macular Degeneration Market

The ophthalmic gene therapy industry is experiencing significant transformation as innovative genetic treatments offer new hope for patients with age-related macular degeneration. The Gene Therapy for Age-Related Macular Degeneration Market is valued at USD 1 billion in 2025 and projected to reach USD 5 billion by 2035 at a CAGR of 13.1%. This article explores strategic growth...

0 Comentários 0 Compartilhamentos 7 Visualizações 0 Anterior